Elevated C-Reactive Protein Augments Increased Arterial Stiffness in Subjects With the Metabolic Syndrome

DOI Web Site 被引用文献22件
  • Hirofumi Tomiyama
    From the Second Department of Internal Medicine, Tokyo Medical University (Y.Y.) Health Care Center, Kajima Corporation, Tokyo, Japan.
  • Yutaka Koji
    From the Second Department of Internal Medicine, Tokyo Medical University (Y.Y.) Health Care Center, Kajima Corporation, Tokyo, Japan.
  • Minoru Yambe
    From the Second Department of Internal Medicine, Tokyo Medical University (Y.Y.) Health Care Center, Kajima Corporation, Tokyo, Japan.
  • Kohki Motobe
    From the Second Department of Internal Medicine, Tokyo Medical University (Y.Y.) Health Care Center, Kajima Corporation, Tokyo, Japan.
  • Kazuki Shiina
    From the Second Department of Internal Medicine, Tokyo Medical University (Y.Y.) Health Care Center, Kajima Corporation, Tokyo, Japan.
  • Zaydun Gulnisa
    From the Second Department of Internal Medicine, Tokyo Medical University (Y.Y.) Health Care Center, Kajima Corporation, Tokyo, Japan.
  • Yoshio Yamamoto
    From the Second Department of Internal Medicine, Tokyo Medical University (Y.Y.) Health Care Center, Kajima Corporation, Tokyo, Japan.
  • Akira Yamashina
    From the Second Department of Internal Medicine, Tokyo Medical University (Y.Y.) Health Care Center, Kajima Corporation, Tokyo, Japan.

抄録

<jats:p> We examined whether the presence of an increasing number of metabolic syndrome “disorders” was associated with an increasing pulse wave velocity, which is recognized as a marker of cardiovascular risk, and evaluated whether an elevated plasma C-reactive protein level augments this increasing pulse wave velocity. Using a cross-sectional study design, C-reactive protein, metabolic syndrome–related anthropometric parameters, and pulse wave velocity were measured in 5752 middle-aged Japanese men (44±10 years old). In linear regression analyses, all of the metabolic “disorders” and the logarithm of the C-reactive protein significantly correlated with pulse wave velocity. Multiple linear regression analysis demonstrated that triglycerides, HDL cholesterol, mean blood pressure, fasting glucose, and the logarithm of the C-reactive protein were significant independent positive predictors of pulse wave velocity (R-square=0.38). The presence of an increasing number of metabolic “disorders” in the subjects was associated with an increasing pulse wave velocity (no disorders 1228±139 cm/s ≥3 disorders 1437±250 cm/s; <jats:italic>P</jats:italic> <0.01). Among subjects with the metabolic syndrome, pulse wave velocity was higher in cases with (1508±278 cm/s) than in those without an elevated C-reactive protein (1427±243 cm/s; <jats:italic>P</jats:italic> <0.01). In conclusion, an increase in arterial stiffness may constitute a pathophysiological basis for the increased risk of cardiovascular disease in patients with the metabolic syndrome and that an elevated C-reactive protein level may aggravate this cardiovascular risk. </jats:p>

収録刊行物

  • Hypertension

    Hypertension 45 (5), 997-1003, 2005-05

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (22)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ